TY  - RPRT
TI  - Sacituzumab Govitecan as an Effective Strategy for Sensitizing Chemoresistant HNSCC Cells to Senolytic Intervention
AU  - Luffman, N.
AU  - Hu, B.
AU  - Koblinski, J.
AU  - Gewirtz, D.
AU  - Harada, H.
PY  - 2026
DO  - 10.64898/2026.04.13.718209
UR  - https://www.biorxiv.org/content/10.64898/2026.04.13.718209v1
ID  - 10.64898/2026.04.13.718209
ER  -